QUONSET, R.I. (PRWEB) September 24, 2020
Helmet ventilation has been newly adopted in the US as a means to reduce the need for endotracheal intubation. This technique provides the ability to elevate patient airway pressure, deliver therapeutic oxygen, and mitigate viral exposure to the healthcare workers.
As part of their Covid-19 response, Ambifi has afforded its global no-code SaaS platform to the helmet based ventilation community to create a digital “Clinician Copilot” including SmartProcedures (video, images, audio, text), interactive checklists and related information to realtime guide clinicians through the protocols needed to safely implement this ventilation technique. “It’s like having experienced clinicians by your side teaching and guiding you every step of the way - except on your mobile device”.
Ambifi has worked cooperatively with Lombardi Undersea LLC to develop and publish a digital clinician copilot including a set of SmartProcedures for the new Subsalve Oxygen Treatment Hood. The Subsalve Hood is the only US domestically manufactured helmet ventilation device that is specifically indicated for respiratory distress per its recent FDA Emergency Use Authorization. With support from a STEP Grant through the State of Rhode Island, the Subsalve Ambifi Clinician Copilot has been translated into Spanish, Portuguese, French, and Chinese to help bring this important technology and technique to international markets.
The AmbiFi Clinician Copilot can be implemented bedside, used for staff training, and further customized by clinicians and staff for any hospital specific protocols. With anticipated Covid-19 surges for this fall and winter, helmet ventilation could become a critical technique to improve patient outcomes and reduce hospital burdens. More can be found at http://www.oxygentreatmenthoods.com and http://www.ambifi.com.